Why is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 12.30% and Operating profit at 11.02% over the last 5 years
2
Flat results in Jun 26
- ROCE(HY) Lowest at 15.53%
3
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
4
Below par performance in long term as well as near term
- Along with generating -12.16% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Anuh Pharma for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Anuh Pharma
-12.16%
-0.38
31.61%
Sensex
-2.63%
-0.19
13.57%
Quality key factors
Factor
Value
Sales Growth (5y)
12.30%
EBIT Growth (5y)
11.02%
EBIT to Interest (avg)
49.00
Debt to EBITDA (avg)
0.24
Net Debt to Equity (avg)
-0.15
Sales to Capital Employed (avg)
2.12
Tax Ratio
24.31%
Dividend Payout Ratio
15.87%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
19.55%
ROE (avg)
15.22%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
37
Price to Book Value
2.33
EV to EBIT
15.42
EV to EBITDA
12.55
EV to Capital Employed
2.57
EV to Sales
0.99
PEG Ratio
NA
Dividend Yield
3.66%
ROCE (Latest)
16.65%
ROE (Latest)
11.65%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish






